Alignment Healthcare, Inc. $ALHC Stake Raised by 1492 Capital Management LLC

1492 Capital Management LLC grew its position in Alignment Healthcare, Inc. (NASDAQ:ALHC) by 61.8% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 324,865 shares of the company’s stock after buying an additional 124,143 shares during the period. Alignment Healthcare makes up about 2.5% of 1492 Capital Management LLC’s investment portfolio, making the stock its 9th largest holding. 1492 Capital Management LLC’s holdings in Alignment Healthcare were worth $6,416,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. BNP Paribas Financial Markets lifted its holdings in shares of Alignment Healthcare by 109.1% during the fourth quarter. BNP Paribas Financial Markets now owns 275,278 shares of the company’s stock valued at $5,437,000 after purchasing an additional 143,656 shares in the last quarter. Norges Bank purchased a new stake in Alignment Healthcare during the fourth quarter valued at $5,143,000. Northwestern Mutual Wealth Management Co. lifted its holdings in Alignment Healthcare by 7,684,933.3% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 691,653 shares of the company’s stock valued at $13,660,000 after acquiring an additional 691,644 shares during the period. Jupiter Asset Management Ltd. boosted its position in Alignment Healthcare by 264.1% in the fourth quarter. Jupiter Asset Management Ltd. now owns 765,233 shares of the company’s stock worth $15,113,000 after purchasing an additional 555,063 shares during the last quarter. Finally, Intech Investment Management LLC increased its position in shares of Alignment Healthcare by 21.9% during the 4th quarter. Intech Investment Management LLC now owns 78,301 shares of the company’s stock valued at $1,546,000 after purchasing an additional 14,065 shares during the last quarter. Hedge funds and other institutional investors own 86.19% of the company’s stock.

Alignment Healthcare Price Performance

NASDAQ:ALHC opened at $14.25 on Thursday. The business’s 50-day moving average is $18.43 and its 200 day moving average is $19.34. Alignment Healthcare, Inc. has a 12 month low of $11.63 and a 12 month high of $23.87. The company has a market capitalization of $2.95 billion, a P/E ratio of 158.33, a P/E/G ratio of 1.91 and a beta of 1.14. The company has a current ratio of 1.58, a quick ratio of 1.58 and a debt-to-equity ratio of 1.56.

Alignment Healthcare (NASDAQ:ALHC) last released its quarterly earnings results on Thursday, April 30th. The company reported $0.05 earnings per share for the quarter, beating the consensus estimate of $0.01 by $0.04. The business had revenue of $1.24 billion during the quarter, compared to analysts’ expectations of $1.22 billion. Alignment Healthcare had a return on equity of 11.50% and a net margin of 0.47%.The firm’s revenue for the quarter was up 33.3% compared to the same quarter last year. During the same quarter last year, the business posted ($0.05) EPS. On average, equities research analysts forecast that Alignment Healthcare, Inc. will post 0.19 earnings per share for the current fiscal year.

Insider Buying and Selling at Alignment Healthcare

In other Alignment Healthcare news, CEO John E. Kao sold 298,000 shares of Alignment Healthcare stock in a transaction on Monday, May 11th. The shares were sold at an average price of $16.89, for a total value of $5,033,220.00. Following the completion of the transaction, the chief executive officer directly owned 1,508,641 shares of the company’s stock, valued at $25,480,946.49. This trade represents a 16.49% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Dawn Christine Maroney sold 36,749 shares of the stock in a transaction dated Wednesday, March 18th. The shares were sold at an average price of $17.84, for a total transaction of $655,602.16. Following the completion of the transaction, the president directly owned 1,058,813 shares of the company’s stock, valued at approximately $18,889,223.92. The trade was a 3.35% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 1,548,741 shares of company stock valued at $29,039,941 in the last quarter. 5.20% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several brokerages have recently weighed in on ALHC. Weiss Ratings upgraded shares of Alignment Healthcare from a “sell (d-)” rating to a “hold (c-)” rating in a research note on Thursday, May 7th. JPMorgan Chase & Co. lifted their price objective on Alignment Healthcare from $23.00 to $26.00 and gave the company an “overweight” rating in a research report on Thursday, February 5th. Raymond James Financial set a $22.00 target price on shares of Alignment Healthcare in a report on Thursday, May 7th. Wolfe Research initiated coverage on shares of Alignment Healthcare in a research report on Friday, April 17th. They issued an “outperform” rating and a $24.00 price target for the company. Finally, Barclays cut their price target on Alignment Healthcare from $19.00 to $16.00 and set an “equal weight” rating for the company in a research note on Tuesday, May 26th. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $24.30.

Trending Headlines about Alignment Healthcare

Here are the key news stories impacting Alignment Healthcare this week:

• Positive Sentiment: Alignment Healthcare was named to Fortune’s 2026 Fortune 1000 list for the second year in a row, rising more than 196 spots to No. 791. The recognition highlights strong operating momentum, with fiscal 2025 revenue up 46.1% to $3.95 billion and membership growth driving results. Article: Alignment Healthcare Named to the Fortune 1000 2026 List for Second Consecutive Year
• Positive Sentiment: Recent commentary says the stock may be oversold after its steep multi-week decline, with analysts still revising earnings estimates higher. That has fueled expectations for a possible near-term turnaround. Article: Down 25.5% in 4 Weeks, Here’s Why Alignment Healthcare (ALHC) Looks Ripe for a Turnaround
• Positive Sentiment: Insider buying also provided a confidence signal, with insider Mark Kent purchasing 14,848 shares at $13.31 each. Article: Insider Buying: Alignment Healthcare (NASDAQ:ALHC) Insider Buys 14,848 Shares of Stock
• Neutral Sentiment: The company also announced executive leadership updates, including John Kao assuming the role of chairman. This is more of a governance update than a direct operating catalyst. Article: Alignment Healthcare (ALHC) Announces Executive Leadership Updates as John Kao Assumes Role of Chairman
• Neutral Sentiment: Another note on valuation and prior analyst downgrades may be keeping investors focused on the stock’s sharp pullback, even as longer-term fundamentals remain tied to revenue growth and Medicare Advantage expansion. Article: A Look At Alignment Healthcare (ALHC) Valuation After Analyst Downgrades And A Sharp 30-Day Share Price Slide
• Negative Sentiment: Some recent coverage emphasized that the stock had fallen sharply over the prior month and was hit by analyst downgrades, which helps explain why sentiment remains mixed despite the positive company news. Article: Alignment Healthcare (ALHC) Slashes 13% on Analyst Downgrade

Alignment Healthcare Company Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.